AMP-activated protein kinase inhibitor decreases prostaglandin F2α-stimulated interleukin-6 synthesis through p38 MAP kinase in osteoblasts

Kondo,Akira; Otsuka,Takanobu; Kato,Kenji; Natsume,Hideo; Kuroyanagi,Gen; Mizutani,Jun; Ito,Yoshiki; Matsushima-Nishiwaki,Rie; Kozawa,Osamu; Tokuda,Haruhiko

doi:10.3892/ijmm.2012.1159

December 2012 Volume 30 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

December 2012 Volume 30 Issue 6

Full Size Image

Article

AMP-activated protein kinase inhibitor decreases prostaglandin F2α-stimulated interleukin-6 synthesis through p38 MAP kinase in osteoblasts

Authors:
- Akira Kondo
- Takanobu Otsuka
- Kenji Kato
- Hideo Natsume
- Gen Kuroyanagi
- Jun Mizutani
- Yoshiki Ito
- Rie Matsushima-Nishiwaki
- Osamu Kozawa
- Haruhiko Tokuda
View Affiliations / Copyright

Affiliations: Department of Orthopedic Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan, Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan, Department of Clinical Laboratory, National Center for Geriatrics and Gerontology, Obu, Aichi 474-8511, Japan
Pages: 1487-1492
|
Published online on: October 15, 2012

https://doi.org/10.3892/ijmm.2012.1159
Expand metrics +

Abstract

We previously showed that prostaglandin F2α (PGF2α) stimulates the synthesis of interleukin-6 (IL-6), a potent bone resorptive agent, in part via p44/p42 mitogen-activated protein (MAP) kinase and p38 MAP kinase but not stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) among the MAP kinase superfamily in osteoblast-like MC3T3-E1 cells. In the present study, we investigated the involvement of AMP-activated protein kinase (AMPK), an intracellular energy sensor, in PGF2α-stimulated IL-6 synthesis in MC3T3-E1 cells. PGF2α time-dependently induced the phosphorylation of the AMPK α-subunit. Compound C, an inhibitor of AMPK, dose-dependently suppressed PGF2α-stimulated IL-6 release. Compound C reduced the PGF2α-induced acetyl-CoA carboxylase phosphorylation. In addition, PGF2α-stimulated IL-6 release in human osteoblasts was also inhibited by compound C. The IL-6 mRNA expression induced by PGF2α was markedly reduced by compound C. Downregulation of the AMPK α1-subunit by short interfering RNA (siRNA) significantly suppressed the PGF2α-stimulated IL-6 release. PGF2α-induced phosphorylation of p38 MAP kinase was inhibited by compound C, which failed to affect the p44/p42 MAP kinase phosphorylation. These results strongly suggest that AMPK regulates PGF2α-stimulated IL-6 synthesis via p38 MAP kinase in osteoblasts.

View Figures

View References

1.	S FogartyDG HardieDevelopment of protein kinase activators: AMPK as a target in metabolic disorders and cancerBiochim Biophys Acta1804581591201010.1016/j.bbapap.2009.09.01219778642
2.	DG HardieSA HawleyJW ScottAMP-activated protein kinase - development of the energy sensor conceptJ Physiol574715200610.1113/jphysiol.2006.10894416644800
3.	R LageC DieguezA Vidal-PuigM LopezAMPK: a metabolic gauge regulating whole-body energy homeostasisTrends Mol Med14539549200810.1016/j.molmed.2008.09.00718977694
4.	GR SteinbergBE KempAMPK in health and diseasePhysiol Rev8910251078200910.1152/physrev.00011.200819584320
5.	G KarsentyEF WagnerReaching a genetic and molecular understanding of skeletal developmentDev Cell2389406200210.1016/S1534-5807(02)00157-011970890
6.	S Kwan TatM PadrinesS TheoleyreD HeymannY FortunIL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiologyCytokine Growth Factor Rev1549602004
7.	M ShahB KolaA BataveljicTR ArnettB ViolletL SaxonM KorbonitsC ChenuAMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone massBone47309319201010.1016/j.bone.2010.04.59620399918
8.	I KanazawaT YamaguchiS YanoM YamauchiT SugimotoMetformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMPK activation as well as eNOS and BMP-2 expressionBiochem Biophys Res Commun375414419200810.1016/j.bbrc.2008.08.03418721796
9.	JE KimMW AhnSH BaekIK LeeYW KimJY KimJM DanSY ParkAMPK activator, AICAR, inhibits palmitate-induced apoptosis in osteoblastBone43394404200810.1016/j.bone.2008.03.02118502715
10.	WG JangEJ KimKN LeeHJ SonJT KohAMP-activated protein kinase (AMPK) positively regulates osteoblast differentiation via induction of Dlx5-dependent Runx2 expression in MC3T3E1 cellsBiochem Biophys Res Commun40410041009201110.1016/j.bbrc.2010.12.09921187071
11.	K KatoH TokudaS AdachiR Matsushima-NishiwakiH NatsumeK YamakawaY GuT OtsukaO KozawaAMP-activated protein kinase positively regulates FGF-2-stimulated VEGF synthesis in osteoblastsBiochem Biophys Res Commun400123127201010.1016/j.bbrc.2010.08.02420708602
12.	S AkiraT TagaT KishimotoInterleukin-6 in biology and medicineAdv Immunol54178199310.1016/S0065-2776(08)60532-5
13.	D HeymannAV Roussellegp130 Cytokine family and bone cellsCytokine1214551468200010.1006/cyto.2000.074711023660
14.	Y IshimiC MiyauraCH JinT AkatsuF AbeY NakamuraY YamaguchiS YoshikiT MatsudaT HiranoT KishimotoT SudaIL-6 is produced by osteoblasts and induces bone resorptionJ Immunol1453297330319902121824
15.	GD RoodmanInterleukin-6: an osteotropic factor?J Bone Miner Res7475478199210.1002/jbmr.56500705021615755
16.	AJ LittlewoodJ RussellGR HarveyDE HughesRGG RusselM GowenThe modulation of the expression of IL-6 and its receptor in human osteoblasts in vitroEndocrinology12915131520199110.1210/endo-129-3-15131714833
17.	M HelleJPJ BrakenhoffER De GrootLA AardenInterleukin 6 is involved in interleukin 1-induced activitiesEur J Immunol18957959199810.1002/eji.1830180619
18.	CC PilbeamJR HarrisonLG RaiszProstaglandins and bone metabolismPrinciples of Bone BiologyJP BilezikianLG RaiszGA RodanAcademic PressSan Diego, CA979994200210.1016/B978-012098652-1/50156-6
19.	O KozawaA SuzukiH TokudaT UematsuProstaglandin F_2α stimulates interleukin-6 synthesis via activation of PKC in osteoblast-like cellsAm J Physiol272E208E21119979124324
20.	H TokudaO KozawaA HaradaT Uematsup42/p44 mitogen-activated protein kinase activation is involved in prostaglandin F_2α-induced interleukin-6 synthesis in osteoblastsCell Signal11325330199910.1016/S0898-6568(98)00048-510376804
21.	C MinamitaniT OtsukaS TakaiR Matsushima-NishiwakiS AdachiY HanaiJ MizutaniH TokudaO KozawaInvolvement of Rho-kinase in prostaglandin F_2α-stimulated interleukin-6 synthesis via p38 mitogen-activated protein kinase in osteoblastsMol Cell Endocrinol2912732200818586382
22.	H SudoH KodamaY AmagaiS YamamotoS KasaiIn vitro differentiation and calcification in a new clonalosteogenic cell line derived from newborn mouse calvariaJ Cell Biol96191198198310.1083/jcb.96.1.1916826647
23.	O KozawaH TokudaM MiwaJ KotoyoriY OisoCross-talk regulation between cyclic AMP production and phosphoinositide hydrolysis induced by prostaglandin E₂ in osteoblast-like cellsExp Cell Res198130134199210.1016/0014-4827(92)90158-51309194
24.	K KatoH ItoK HasegawaY InagumaO KozawaT AsanoModulation of the stress-induced synthesis of hsp27 and α B-crystallin by cyclic AMP in C6 rat glioma cellsJ Neurochem669469501996
25.	UK LaemmliCleavage of structural proteins during the assembly of the head of bacteriophage T4Nature227680685197010.1038/227680a05432063
26.	SA HawleyM DavisonA WoodsSP DaviesRK BeriD CarlingDG HardieCharacterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinaseJ Biol Chem2712787927887199610.1074/jbc.271.44.278798910387
27.	G ZhouR MyersY LiY ChenX ShenJ Fenyk-MelodyM WuJ VentreT DoebberN FujiiN MusiMF HirshmanLJ GoodyearDE MollerRole of AMP-activated protein kinase in mechanism of metformin activationJ Clin Invest10811671174200110.1172/JCI1350511602624
28.	JM KyriakisJ AvruchMammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammationPhysiol Rev81807869200111274345
29.	D StapletonG GaoBJ MichellJ WidmerK MitchelhillT TehCM HouseLA WittersBE KempMammalian 5′-AMP-activated protein kinase non-catalytic subunits are homologs of proteins that interact with yeast Snf1 protein kinaseJ Biol Chem26929343293461994
30.	H TokudaS TakaiR Matsushima-NishiwakiS AkamatsuY HanaiT HosoiA HaradaT OhtaO Kozawa(−)-Epigallocatechin gallate enhances prostaglandin F_2α-induced VEGF synthesis via up-regulating SAPK/JNK activation in osteoblastsJ Cell Biochem100114611532007
31.	GA RutterI LeclercThe AMP-regulated kinase family: enigmatic targets for diabetes therapyMol Cell Endocrinol2974149200910.1016/j.mce.2008.05.02018611432
32.	Q MaiZ ZhangS XuM LuR ZhouL ZhaoC JiaZ WenD JinX BaiMetformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized ratsJ Cell Biochem11229022909201110.1002/jcb.2320621618594
33.	A UnnanuntanaBP GladnickE DonnellyJM LaneThe assessment of fracture riskJ Bone Joint Surg Am92743753201010.2106/JBJS.I.00919

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

AMP-activated protein kinase inhibitor decreases prostaglandin F2α-stimulated interleukin-6 synthesis through p38 MAP kinase in osteoblasts

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Figure 9

Related Articles